{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:54:02Z","timestamp":1790816042340,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.contraception.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T18:24:01Z","timestamp":1093631041000},"page":"233-240","source":"Crossref","is-referenced-by-count":36,"title":["A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II"],"prefix":"10.1016","volume":"70","author":[{"given":"Christine K.","family":"Mauck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra H.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt T.","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne M.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2004.04.010_BIB1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers","volume":"360","author":"Van Damme","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2004.04.010_BIB2","series-title":"Vaginal microbicide formulations workshop","first-page":"79","article-title":"Formulation of C31G as a vaginal microbicide","author":"Malamud","year":"1998"},{"key":"10.1016\/j.contraception.2004.04.010_BIB3","first-page":"335","article-title":"A non-antibiotic antimicrobial mixture (C31G)","volume":"131","author":"Calis","year":"1992","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.contraception.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0166-3542(99)00044-3","article-title":"Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate","volume":"43","author":"Krebs","year":"1999","journal-title":"Antiviral Res"},{"key":"10.1016\/j.contraception.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.41.6.1335","article-title":"The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro","volume":"41","author":"Wyrick","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(96)00066-2","article-title":"Assessment of the anti-microbial agent C31G as a spermicide","volume":"53","author":"Thompson","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3168\/jds.S0022-0302(84)81319-3","article-title":"Evaluation of a surfactant mixture C31G as a teat dip by a modified excised teat model","volume":"67","author":"Amin","year":"1984","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.contraception.2004.04.010_BIB8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0010-7824(02)00433-X","article-title":"Safety of single daily use for one week of C31G HEC gel in women","volume":"66","author":"Ballagh","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0010-7824(02)00389-X","article-title":"Microbicides\u2014evaluating multiple formulations of C31G","volume":"66","author":"Bax","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.04.010_BIB10","unstructured":"Manual for the standardization of colposcopy for the evaluation of vaginally administered products, update 2000. Geneva: CONRAD and the World Health Organization, 2000"},{"key":"10.1016\/j.contraception.2004.04.010_BIB11","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/14.8.1974","article-title":"Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women","volume":"14","author":"Fraser","year":"1999","journal-title":"Hum Reprod"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:51:50Z","timestamp":1585878710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782404001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0010782404001295"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2004.04.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}